The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2020

Filed:

Apr. 12, 2019
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Glen Eugene Mikesell, Fremont, CA (US);

Han Chang, West Windsor, NJ (US);

Robert James Peach, San Diego, CA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/705 (2006.01); A61K 38/16 (2006.01); C07K 16/28 (2006.01); C07K 19/00 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70532 (2013.01); A61K 38/1774 (2013.01); A61K 39/39533 (2013.01); C07K 16/2827 (2013.01); C07K 19/00 (2013.01); G01N 33/5005 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/56 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/10 (2013.01); C07K 2319/30 (2013.01); C07K 2319/40 (2013.01); Y02A 50/396 (2018.01);
Abstract

The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.


Find Patent Forward Citations

Loading…